Join
Live feed
·
PRReleasevia Quantisnow
Sana Biotechnology Inc. logo

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

ByQuantisnow·Wall Street's wire, on your screen.
SANA· Sana Biotechnology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SANA (Sana Biotechnology Inc.) and more on Quantisnow.